M Cebolla-Verdugo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M Cebolla-Verdugo

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Semergen|November 19, 2023

[Senile gluteal dermatosis]M Cebolla-Verdugo, A Cabrerizo-Carvajal, R Ruiz-Villaverde

Actas Dermo-Sifiliograficas|December 10, 2025

RF - Tildrakizumab 200mg. Is Double Dosing Really a Window of Opportunity?C Llamas-Segura, M Cebolla-Verdugo, R Ruiz-Villaverde

The Journal of Dermatological Treatment|January 23, 2024

A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiencyM Cebolla-Verdugo, C Llamas-Segura, L Linares-González, et al.

Semergen|May 9, 2025

[Evaluation of the efficacy and concordance between primary and specialized care in the treatment of actinic keratosis using daylight photodynamic therapy monitored by teledermatology]E Almazan-Delgado, A Medina-Cobos, M Cebolla-Verdugo, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Semergen|November 19, 2023

[Senile gluteal dermatosis]M Cebolla-Verdugo, A Cabrerizo-Carvajal, R Ruiz-Villaverde

Actas Dermo-Sifiliograficas|December 10, 2025

RF - Tildrakizumab 200mg. Is Double Dosing Really a Window of Opportunity?C Llamas-Segura, M Cebolla-Verdugo, R Ruiz-Villaverde

The Journal of Dermatological Treatment|January 23, 2024

A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiencyM Cebolla-Verdugo, C Llamas-Segura, L Linares-González, et al.

Semergen|May 9, 2025

[Evaluation of the efficacy and concordance between primary and specialized care in the treatment of actinic keratosis using daylight photodynamic therapy monitored by teledermatology]E Almazan-Delgado, A Medina-Cobos, M Cebolla-Verdugo, et al.

Pageof 1